Bruker Takes $10M in Stimulus Orders | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker said this week that it has taken in $10 million in orders due to stimulus programs in the US, Japan, and Europe.

The firm disclosed in a filing with the US Securities and Exchange Commission that by the end of August it had booked $10 million in orders due the various stimulus programs, with more than $3 million coming from Japan. It said that it had booked five system orders from that country.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.